Founded in April 2018, and based in Geneva, Switzerland, MIKAJAKI, SA is a privately held company that is supported by Innosuisse and powered by FONGIT Innovation Incubator.
MIKAJAKI is actively partnering with ophthalmic clinic groups globally to test and implement EyeLibâ„¢.
Behind the leadership of founders Michael Assouline, MD, PhD, and Jacky Hochner, MIKAJAKI has set out to revolutionize ophthalmic diagnostics. We’re bringing together the best people to build the most advanced eye health diagnostics products in the market.